DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE · DEXTROAMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 7.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1 · Capsule, Extended Release · Patheon Manufacturing Services LLC
NDC 63552-0130-00 · 36000 CAPSULE, EXTENDED RELEASE in 1 DRUM · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE (Capsule, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Patheon Manufacturing Services LLC | DEXTROAMPHETAMINE SULFATE 5 mg/1; DEXTROAMPHETAMINE SACCHARATE 5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1 | Jul 22, 2026 | Sep 2, 2026 |
| Patheon Manufacturing Services LLC | DEXTROAMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 7.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1 | Jul 22, 2026 | Sep 2, 2026 |
| Takeda Pharmaceuticals America, Inc. | DEXTROAMPHETAMINE SULFATE 9.375 mg/1; DEXTROAMPHETAMINE SACCHARATE 9.375 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 9.375 mg/1; AMPHETAMINE SULFATE 9.375 mg/1 | Jul 22, 2026 | Sep 2, 2026 |
| Takeda Pharmaceuticals America, Inc. | DEXTROAMPHETAMINE SULFATE 12.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 12.5 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 12.5 mg/1; AMPHETAMINE SULFATE 12.5 mg/1 | Jul 22, 2026 | Sep 2, 2026 |
| Takeda Pharmaceuticals America, Inc. | DEXTROAMPHETAMINE SULFATE 3.125 mg/1; DEXTROAMPHETAMINE SACCHARATE 3.125 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1 | Jul 22, 2026 | Sep 2, 2026 |
| Takeda Pharmaceuticals America, Inc. | DEXTROAMPHETAMINE SULFATE 6.25 mg/1; DEXTROAMPHETAMINE SACCHARATE 6.25 mg/1; AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1 | Jul 22, 2026 | Sep 2, 2026 |
| Patheon Manufacturing Services LLC | AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPHETAMINE SACCHARATE 5 mg/1; DEXTROAMPHETAMINE SULFATE 5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Patheon Manufacturing Services LLC | AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 7.5 mg/1; DEXTROAMPHETAMINE SULFATE 7.5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Takeda Pharmaceuticals America, Inc. | AMPHETAMINE ASPARTATE MONOHYDRATE 12.5 mg/1; AMPHETAMINE SULFATE 12.5 mg/1; DEXTROAMPHETAMINE SACCHARATE 12.5 mg/1; DEXTROAMPHETAMINE SULFATE 12.5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Takeda Pharmaceuticals America, Inc. | AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DEXTROAMPHETAMINE SACCHARATE 3.125 mg/1; DEXTROAMPHETAMINE SULFATE 3.125 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Takeda Pharmaceuticals America, Inc. | AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXTROAMPHETAMINE SACCHARATE 6.25 mg/1; DEXTROAMPHETAMINE SULFATE 6.25 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Takeda Pharmaceuticals America, Inc. | AMPHETAMINE ASPARTATE MONOHYDRATE 9.375 mg/1; AMPHETAMINE SULFATE 9.375 mg/1; DEXTROAMPHETAMINE SACCHARATE 9.375 mg/1; DEXTROAMPHETAMINE SULFATE 9.375 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE — NDC 63552-0130-00," retrieved September 3, 2026, https://drugdashboards.com/drug/63552013000.
Free to cite with attribution — see how the data is put together.